These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26118635)

  • 21. Increased free water in the substantia nigra of Parkinson's disease: a single-site and multi-site study.
    Ofori E; Pasternak O; Planetta PJ; Burciu R; Snyder A; Febo M; Golde TE; Okun MS; Vaillancourt DE
    Neurobiol Aging; 2015 Feb; 36(2):1097-104. PubMed ID: 25467638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffusion tensor and restriction spectrum imaging reflect different aspects of neurodegeneration in Parkinson's disease.
    Hope TR; Selnes P; Rektorová I; Anderkova L; Nemcova-Elfmarkova N; Balážová Z; Dale A; Bjørnerud A; Fladby T
    PLoS One; 2019; 14(5):e0217922. PubMed ID: 31150514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.
    Hu Z; Sun P; George A; Zeng X; Li M; Lin TH; Ye Z; Wei X; Jiang X; Song SK; Yang R
    Eur Radiol; 2023 Dec; 33(12):9109-9119. PubMed ID: 37438642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging nigral pathology and clinical progression in Parkinson's disease.
    Du G; Lewis MM; Sen S; Wang J; Shaffer ML; Styner M; Yang QX; Huang X
    Mov Disord; 2012 Nov; 27(13):1636-43. PubMed ID: 23008179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteration of putaminal fractional anisotropy in Parkinson's disease: a longitudinal diffusion kurtosis imaging study.
    Surova Y; Nilsson M; Lampinen B; Lätt J; Hall S; Widner H; van Westen D; Hansson O
    Neuroradiology; 2018 Mar; 60(3):247-254. PubMed ID: 29368035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging brain iron and diffusion patterns: a follow-up study of Parkinson's disease in the initial stages.
    Rossi ME; Ruottinen H; Saunamäki T; Elovaara I; Dastidar P
    Acad Radiol; 2014 Jan; 21(1):64-71. PubMed ID: 24331266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study.
    Ofori E; Krismer F; Burciu RG; Pasternak O; McCracken JL; Lewis MM; Du G; McFarland NR; Okun MS; Poewe W; Mueller C; Gizewski ER; Schocke M; Kremser C; Li H; Huang X; Seppi K; Vaillancourt DE
    Mov Disord; 2017 Oct; 32(10):1457-1464. PubMed ID: 28714593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substantia nigra fractional anisotropy changes confirm the PD at-risk status of patients with idiopathic smell loss.
    Haehner A; Schöpf V; Loureiro A; Linn J; Reichmann H; Hummel T; Kitzler HH
    Parkinsonism Relat Disord; 2018 May; 50():113-116. PubMed ID: 29477459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant nigral diffusion in Parkinson's disease: A longitudinal diffusion tensor imaging study.
    Loane C; Politis M; Kefalopoulou Z; Valle-Guzman N; Paul G; Widner H; Foltynie T; Barker RA; Piccini P
    Mov Disord; 2016 Jul; 31(7):1020-6. PubMed ID: 27104232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of diffusion tensor imaging and fractional anisotropy in the evaluation of patients with idiopathic normal pressure hydrocephalus: a literature review.
    Siasios I; Kapsalaki EZ; Fountas KN; Fotiadou A; Dorsch A; Vakharia K; Pollina J; Dimopoulos V
    Neurosurg Focus; 2016 Sep; 41(3):E12. PubMed ID: 27581308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential involvement of corticospinal tract (CST) fibers in UMN-predominant ALS patients with or without CST hyperintensity: A diffusion tensor tractography study.
    Rajagopalan V; Pioro EP
    Neuroimage Clin; 2017; 14():574-579. PubMed ID: 28337412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of Diffusion Kurtosis and Neurite Density Measures in Deep Grey Matter and White Matter in Parkinson's Disease.
    Surova Y; Lampinen B; Nilsson M; Lätt J; Hall S; Widner H; ; van Westen D; Hansson O
    PLoS One; 2016; 11(6):e0157755. PubMed ID: 27362763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.
    Ofori E; Pasternak O; Planetta PJ; Li H; Burciu RG; Snyder AF; Lai S; Okun MS; Vaillancourt DE
    Brain; 2015 Aug; 138(Pt 8):2322-31. PubMed ID: 25981960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
    Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
    NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.
    Langley J; Huddleston DE; Merritt M; Chen X; McMurray R; Silver M; Factor SA; Hu X
    Hum Brain Mapp; 2016 Jul; 37(7):2547-56. PubMed ID: 27029026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra.
    Zhong Z; Merkitch D; Karaman MM; Zhang J; Sui Y; Goldman JG; Zhou XJ
    Radiology; 2019 Apr; 291(1):149-157. PubMed ID: 30777809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.